Date: October 1, 2026
KMP / Board / Auditor Changes
This disclosure pertains to authorization changes rather than appointment/resignation of Key Managerial Personnel. The following individuals are now authorized for SEBI LODR compliance functions:
- Shri Adhish P. Patil, Managing Director - Authorized for determining materiality of events/information and making disclosures to Stock Exchange
- Shri Harshit M. Savla, Jt. Managing Director - Authorized for determining materiality of events/information and making disclosures to Stock Exchange
- Rushikesh V. Deole, Company Secretary and Compliance Officer - Authorized for making disclosures to Stock Exchange
Board Meeting Outcomes
Not specified
Financial Results
Not specified
Dividend Declaration or Non-Declaration
Not specified
Disinvestment / Strategic Actions
Not specified
Other Operational / Legal / Strategic Disclosures
This is a compliance disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The authorization changes are effective from October 1, 2026, and are consequent to recent changes in the Directorate/Management of the Company.
The information has been made available on the Company's website at https://www.aartidrugs.com/
Contact details provided:
- Managing Director and Jt. Managing Director: mgnt@aartidrugs.com
- Company Secretary and Compliance Officer: investorrelations@aartidrugs.com